About
Tron Group Inc (PINK:TGRP) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 3 2025
Alchem Announces Poster Presentation on its AD=229 Program at Society for Neuroscience 2025 Conference
Oct 20 2025
Dr. Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025
Oct 13 2025
ESMO Abstract “1709MO - Multi-center NCI-sponsored phase I study of triapine in combination with 177Lu-dotatate in patients with well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NETs)”
Sep 10 2025
Nanopharmaceutics Announces Presentation of National Cancer Institute sponsored Phase I Study with Triapine at ESMO 2025
Jul 18 2025
Nanopharmaceutics Announces End of Patient Recruitment for NCI Phase II Study with Triapine for Neuroendocrine Tumors
Financials
Revenue
$1.01 M
Market Cap
$7.36 M
EPS
0.00